Topical administration means drug delivery via application on body surfaces, such as the skin or mucus membranes, including nasal sprays and ophthalmic drops.
The market is majorly driven by increased patient compliance, owing to the potential for self and painless administration. High incidence of skin diseases like eczema, psoriasis, etc. and minor ailments like acne contribute to the market expansion.
High initial capital requirements, presence of strict regulatory framework, and frequent product recalls like Philips’ voluntary recall of topical antibiotic products in June, 2017.
The global topical drug delivery market has been segmented, based on the routes of administration (dermal, ophthalmic, nasal, oral topical, vaginal, and others), by products (Formulation- Solid, Semi-solid and liquid devices) and by region (North America, Europe, Asia-Pacific, Middle East and Africa, South America)
The report provides a detailed overview of each type of topical drug delivery method, along with an in-depth analysis, in addition to the company profiles of major players in the space and a clear picture of a competitive landscape that currently exists in the market.
Some of the key players in the global topical drug delivery market include:
GlaxoSmithKline, Galderma, Bayer, Valeant pharmaceuticals, Novartis, Medpharm, Hisamitsu pharmaceuticals, Johnson & Johnson, and Crescita therapeutics are some of the key players in the global topical drug delivery market.
Market analysis for the global topical drug delivery market, with region-specific assessments and competition analysis.
Market definition, along with the identification of key drivers, restraints, opportunities, and challenges.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section, company profiles of key players, with the analysis of the current strategic interests and key financial information.
Identification and analysis of the macro and micro factors that affect the global topical drug delivery market.
Insights of the market in the regions that have the highest potential for growth and identification of untapped markets.
Global Novel Drug Delivery Systems (NDDS) Market
Global Injectable Drug Delivery Devices Market
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Ease of Drug Delivery
6.1.2 High Prevalence of Skin Diseases
6.2 Market Restraints
6.2.1 Stringent Approval Process
6.2.2 High Frequency of Product Recalls
6.4 Key Challenges
7. Market Segmentation
7.1 Segmentation-By Route of Administration
7.1.4 Oral Topical
7.2 Segmentation-By Product
188.8.131.52.1 Cream & Lotion
7.3 Segmentation-By Geography
7.3.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest Of Europe
22.214.171.124 Australia & New Zealand
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
7.3.4 Middle East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle East & Africa
7.3.5 South America
18.104.22.168 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisitions Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Product Launches
9. Key Players
9.4 Valeant Pharmaceuticals
9.7 Hisamitsu Pharmaceuticals
9.8 Johnson & Johnson
9.9 Crescita Therapeutics
10. Future of the Market